drugset / Trial / NCT01646255
Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study was to demonstrate that Rotigotine transdermal patch is efficacious in Chinese subjects with advanced-stage Idiopathic Parkinson's Disease as an adjuvant therapy.
Timeline
- Start
- 2012-07
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rotigotine | Unknown | 4 mg | Other |
| Subject | Rotigotine | Unknown | 6 mg | Other |
| Subject | Rotigotine | Unknown | 8 mg | Other |
| Subject | Rotigotine | Unknown | 16 mg | Other |
| Background | Levodopa | Small molecule | — | — |